Type I Interferon in Children with Viral or Bacterial Infections
Sophie Trouillet‐Assant, Sébastien Viel, Antoine Ouziel, Lucille Boisselier, P Rebaud, Romain Basmaci, Nina Droz, Alexandre Bélot, Sylvie Pons, Karen Brengel‐Pesce, Yves Gillet, Étienne Javouhey, Antoine Study Group, Marine Mommert, Audrey Guichard, François Bartolo, Laurence Generenaz, Alexandre Pachot, Claire Capella, Laure Hees, Ellia Mezgueldi, Chadia Toumi, Coralie Bouchiat-Sarabi, Jean‐Sébastien Casalegno, Aurélie Portefaix, Romain Deshayes de Cambronne, Magali Perret
Abstract
BACKGROUND: Fever is one of the leading causes of consultation in the pediatric emergency department for patients under the age of 3 years. Distinguishing between bacterial and viral infections etiologies in febrile patients remains challenging. We hypothesized that specific host biomarkers for viral infections, such as type I-interferon (IFN), could help clinicians' decisions and limit antibiotic overuse. METHODS: Paxgene tubes and serum were collected from febrile children (n = 101), age from 7 days to 36 months, with proven viral or bacterial infections, being treated at pediatric emergency departments in France. We assessed the performance of an IFN signature, which was based on quantification of expression of IFN-stimulated genes using the Nanostring® technology and plasma IFN-α quantified by digital ELISA technology. RESULTS: Serum concentrations of IFN-α were below the quantification threshold (30 fg/mL) for 2% (1/46) of children with proven viral infections and for 71% (39/55) of children with bacterial infections (P < 0.001). IFN-α concentrations and IFN score were significantly higher in viral compared to bacterial infection (P < 0.001). There was a strong correlation between serum IFN-α concentrations and IFN score (p-pearson = 0.83). Both serum IFN-α concentration and IFN score robustly discriminated (Area Under the Curve >0.91 for both) between viral and bacterial infection in febrile children, compared to C-reactive protein (0.83). CONCLUSIONS: IFN-α is increased in blood of febrile infants with viral infections. The discriminative performance of IFN-α femtomolar concentrations as well as blood transcriptional signatures could show a diagnostic benefit and potentially limit antibiotic overuse. CLINICAL TRIALS REGISTRATION: clinicaltrials.gov (NCT03163628).